Question: How can metagenomic next-generation sequencing of cerebrospinal fluid be leveraged to aid in the diagnosis of patients with subacute or chronic meningitis?
performed mNGS on total RNA extracted from CSF of patients with subacute or chronic meningitis and highlight seven cases representing a diverse array of pathogens.
Setting: A multi-center study of mNGS pathogen discovery in patients with suspected neuroinflammatory conditions.
Participants:
Patients with diagnostically challenging subacute or chronic meningitis enrolled in a research study of mNGS performed on CSF.
Intervention: mNGS was performed on total RNA extracted from CSF (0.25-0.5 mL). A weighted z-score was used to filter out environmental contaminants and facilitate efficient data triage and analysis.
Main Outcomes: 1) Pathogens identified by mNGS and 2) ability of a statistical model to prioritize, rank, and simplify mNGS results.
Results: mNGS identified parasitic worms, fungi and viruses in seven subjects: Taenia solium (n=2), Cryptococcus neoformans, human immunodeficiency virus-1, Aspergillus oryzae, Histoplasma capsulatum, and Candida dubliniensis. Evaluating mNGS data with a weighted z-score based scoring algorithm effectively separated bona fide pathogen sequences from spurious environmental sequences.
Conclusions and Relevance: mNGS of CSF identified a diversity of microbial pathogens in patients with diagnostically challenging subacute or chronic meningitis, including a case of subarachnoid neurocysticercosis that defied diagnosis for one year, the first case of CNS vasculitis caused by Aspergillus oryzae, and the fourth reported case of Candida dubliniensis meningitis. Filtering metagenomic data with a scoring algorithm greatly clarified data interpretation and highlights the difficulties attributing biological significance to organisms that may be present in control samples used for metagenomic sequencing studies.
Introduction: Subacute and chronic meningitis is diagnostically challenging given the wide range of potential infectious, autoimmune, neoplastic, paraneoplastic, parameningeal and toxic causes.
1,2 Securing a final diagnosis can require weeks or months of testing, and in many cases is never achieved, necessitating empiric treatment approaches that may be ineffective or even harmful.
Unlike traditional testing for a specific microbe or category of infection, metagenomic next-generation sequencing (mNGS) of cerebrospinal fluid (CSF) or brain tissue screens for all potential CNS pathogens, and can identify novel or unexpected infections in people suffering from unexplained meningitis and/or encephalitis. [3] [4] [5] [6] [7] [8] [9] [10] Multiple computational algorithms and pipelines have been developed to rapidly identify microbial sequences in mNGS datasets. [11] [12] [13] However, the unbiased nature of mNGS data requires careful analysis to determine which, if any, of the identified microbes represent a true pathogen versus an environmental contaminant. Failure to make this distinction has resulted in disease associations with organisms later determined to be laboratory contaminants.
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Here, we developed a straightforward statistical approach leveraging an extensive mNGS database of water-only controls (n=24) and surplus CSF samples (n=94)
obtained from patients with clinically adjudicated non-infectious neurologic diagnoses ranging from autoimmune, neoplastic, structural and neurodegenerative etiologies ("control cohort"). These data allow one to quantify how unexpected it is to identify a particular microbe at a given level of abundance in a patient sample by comparison to its mean level of abundance across the control cohort. Here we report the utility of this statistical framework for identifying microbial pathogens in seven challenging cases of subacute or chronic meningitis, as well as for analyzing publicly available data from recent mNGS infectious diagnostic and brain microbiota studies.
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METHODS:
Participants were recruited between September 2013 and March 2017 as part of a larger study applying mNGS to biological samples from patients with suspected neuroinflammatory disease. mNGS Protocol mNGS was performed on total RNA extracted from surplus CSF (250-500 µL). In addition to CSF, one subject also had mNGS performed on total RNA extracted from <50 mg of snap frozen, surplus tissue from a lumbar meningeal biopsy. Samples were processed for mNGS as previously described. 5, 7 The non-human sequence reads have from each sample have been deposited at the National Center for Biotechnology Information (NCBI) Sequence Read Archive, BioProject (PRJNA338853).
Bioinformatics
Paired-end 125-150 base pair (bp) sequences were analyzed using a previously described rapid computational pathogen detection pipeline (Figure 1) . 5, 7 Unique, nonhuman sequences were assigned to microbial taxonomic identifiers (taxids) based on nucleotide (nt) and non-redundant (nr) protein alignments. To distinguish putative pathogens from contaminating microbial sequences derived from skin, collection tubes, lab reagents, or the environment, a composite background model of metagenomic data was employed. This model incorporated 24 water controls and 94 CSF samples from patients with non-infectious diagnoses, including 21 chronic meningitis cases with the following diagnoses: neurosarcoidosis (n=7), CNS vasculitis (n=5), autoimmune encephalitis, parameningeal dermoid cyst, leptomeningeal carcinomatosis, CNS lymphoma, melanoma, Susac syndrome, and a meningitis syndrome responsive to immunosuppression. Data were normalized to unique reads mapped per million input reads (rpM) for each microbe at the species and genus level. Using this background dataset as the expected mean rpM for a given taxid, standard Z-scores were calculated for each genus (gs) and species (sp) in each sample based on the results from both the nt and nr database searches. Thus, there are four z-scores reported for each sample:
spZnt, gsZnt, spZnr and gsZnr. To prioritize reporting of the most unique (i.e., unexpected) taxa in each sample, the significance of each microbial species was mapped to a single value with the following empirically-derived formula:
Here, the rpM are scaled by both the z-score for the species and the genus. If both zscores are negative, the product remains negative. The maximum z-score is arbitrarily capped at 100. This product is calculated for alignments to both the nt and nr databases and summed. The top-ranked taxa were considered with respect to the clinical context of the patient. Microbes with known CNS pathogenicity that could cause a clinical phenotype concordant with the clinical presentation were considered potential pathogens and were confirmed by standard microbiologic assays, as described in the brief case histories below.
RESULTS:
The seven study subjects ranged in age from 10 to 55 years old, and three (43%) were female. Additional clinical details are listed in Table 1 . In each case, the causative pathogen was identified within the top two scoring microbes identified by our algorithm (Figure 2 ). (Table 2) Figure 2 ).
Case Descriptions
After two months of treatment, she could ambulate but continues to have profound left hearing loss, facial weakness, and a neurogenic bladder.
Candida dubliniensis
Participant 7 was a 26 year-old woman with an undisclosed history of IDU who presented with one year of atraumatic lower back pain followed by subacute development of saddle anesthesia and left foot drop. On MRI, she had a loculated, rimenhancing collection extending from the top of the lumbar spine anteriorly compressing the conus medullaris against the posterior wall, in addition to diffuse leptomeningitis involving the entire spinal cord and brainstem ( Figure 3C-E Candida dubliniensis with 99-100% identity. A CSF 1,3-ß-D-glucan assay was 211 pg/mL (<80 pg/mL), whereas the serum 1,3-ß-D-glucan assay had been repeatedly normal.
Repeat CSF 18s rRNA and 16s rRNA PCRs were negative. The patient is being treated with combination anti-fungal therapy with mild clinical improvement, normalization of her CSF profile (including a negative CSF 1,3-ß-D-glucan) and decreasing leptomeningeal enhancement on MRI. Two of the previous three reported cases of Candida dubliniensis meningitis were also in patients with a history of IDU.
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Background Signature of Reagent and Environmental Contaminants
Examination of nucleotide alignments generated by non-templated water-only controls common soil, skin, and environmental flora previously reported as laboratory and reagent contaminants. 16 To determine if these common microbial contaminants may have been misclassified as pathogens in previously published studies, we examined publicly available data from two cases of meningoencephalitis for which a possible infection was identified by mNGS. 19 In each case, neither organism (Delftia acidovorans, Elizabethkingia) was present at levels significantly greater than the mean of our background dataset of water-only and non-infectious CSF controls (Supplementary Figure 1D) . We then examined data from a study aiming to characterize the "brain microbiome" and correlate brain dysbiosis to disease. 17, 18 The abundance of the purported brain microbiota reveal distributions that are well within the observed variance we observe within our set of background water-only controls (Supplementary Figure 1C) .
Of note, the authors of the brain microbiome study did not deep sequence water controls from which they could not generate measurable quantities of DNA after reverse transcription-PCR (RT-PCR). The presence of environmental contaminants may likely be a function of low amounts of input RNA, which is often the case with acellular CSF samples. To test this explicitly, we performed an RNA doping experiment (Supplemental Figure 2 ) on a water sample and an uninfected CSF sample from which there was no detectable cDNA after RT-PCR. The mNGS libraries made from the water and CSF samples had 9.4% and 7.6% unique, non-human sequences, respectively. The proportion of non-human sequences dropped dramatically after spiking in only 20 picograms of RNA of a known identity suggesting that non-human environmental sequences are particularly problematic for low input nucleic acid samples.
Discussion
We present seven diagnostically challenging cases of subacute and chronic meningitis in which mNGS of CSF identified a pathogen, including a case of subarachnoid neurocysticercosis that defied diagnosis for one year, the first case of CNS vasculitis caused by Aspergillus oryzae, and the fourth reported case of Candida dubliniensis meningitis. A straightforward statistical model leveraging a large mNGS dataset obtained from water-only controls and patients with a variety of non-infectious neuroinflammatory syndromes correctly prioritized the pathogens.
CSF mNGS has the potential to overcome several limitations of conventional CNS infectious disease diagnostics. First, the inherent risks of brain and/or meningeal biopsy make CSF mNGS a particularly attractive option for patients with suspected CNS infection. Second, the large number of neuroinvasive pathogens that cause subacute or chronic meningitis makes it logistically challenging and cost-prohibitive to order every possible neuro-infectious diagnostic test using a candidate-based approach. Third, some assays lack sensitivity in the context of impaired immunity or acute infection (e.g., West
Nile virus serology), can be slow to yield results (e.g., mycobacterial and fungal cultures)
or may fail to differentiate between active infection and prior exposure (e.g., cysticercosis antibody or the interferon-gamma release assay test for M. tuberculosis).
The unbiased nature of mNGS makes the datasets inherently polymicrobial and complex. Thus, statistical scoring and filtering is essential to enhance the ability to discriminate between insignificant contaminants and true infectious organisms. Our algorithm correctly prioritized etiologic pathogens in these seven clinically-confirmed cases of infectious meningitis despite the fact that the pathogens ranged widely with regard to their absolute abundance (33-136,000 sequence read pairs) and the proportion of the non-human sequences (0.89-92.7%) that they comprised (Table 2 ).
In addition, we analyzed a recently published clinical mNGS dataset to highlight that a thoroughgoing profile of the microbes present in water-only controls and non-infectious CSF reinforces the skepticism with which the authors described a possible infection in one subject with Delftia acidovorans (patient 2) and in another subject with Elizabethkingia (patient 7) (Supplementary Figure 1D) . Furthermore, such a database could help improve the accuracy of microbiome studies, especially for body sites historically considered sterile in which rigorous controls are necessary to establish that observed microbial sequences represent microbiota vs environmental contaminants (Supplementary Figure 1C) . 18, 19 This problem appears to be particularly acute in samples like CSF whose sub-nanogram levels of input RNA/DNA require unbiased molecular amplification steps before enough material is available for sequencing applications.
Indeed, the addition of only 20 picograms of purified RNA to a CSF sample was sufficient to suppress the majority of non-CSF reads deriving from the water and reagents (Supplemental Figure 2) . While amplifying the input signal increases the sensitivity of the assay, it also often over-represents the signature of contaminating taxa unique to a given laboratory, experimenter, or reagent lot. 14,16 . These results provide a cautionary note and underscore the need for appropriate controls to aid in interpretation.
We expect larger databases of patient mNGS results will only enhance the ability to discriminate between irrelevant sequences and legitimate pathogens and permit more rigorous and probabilistic models for pathogen ranking and reporting. We present here one empirically derived system for prioritizing results, based on the read count weighted by standard z-scores. Given the sensitivity of NGS-based approaches, we anticipate individual laboratories will need to develop their own dynamic reference datasets to control for contaminants that are relevant to the particular time, place, and manner in which the biological samples are being analyzed. For detection of possible pathogen-derived sequences, a rapid pipeline was implemented as diagrammed. The CSF sample from participant 1 yielded 13,141,550 million read pairs, which were then subjected to human removal (STAR v2.4 Strip plot of normalized species significance scores for microbial taxa (dots) in each patient sample (row). In 6/7 samples, the neurologic infection (red dots) is ranked as the most significant by our approach. In the case of participant 5, Aspergillus oryzae is ranked second behind GB virus C, a likely concurrent infection unrelated to the clinical presentation. control (column 2) and the decrease in the percent non-human sequences found with increasing amounts of spiked RNA of a known identity (columns 3-7). Added RNA was generated by T7 in vitro transcription from a cloned luciferase reporter gene, purified, quantified, and spiked into the CSF at the indicated amounts. These data suggest that common environmental contaminants are present at low picogram quantities, and the addition of only 20 pg is sufficient to suppress the majority of reads not derived from the CSF.
